A Michigan Circuit Court judge has reached a decision that might be pivotal in a case concerning a man who claims to have been harmed by Remdesivir.
Dan Nowacki, from metro Detroit, underwent two strokes and a leg amputation in 2021 after he was treated with several doses of Remdesivir manufactured by Gilead Sciences.
The Public Readiness and Emergency Preparedness (PREP) Act typically offers legal immunity to the producers of Remdesivir and COVID-19 vaccines if consumers suffer physical injuries from their products.
However, in a ruling given last week, the judge determined that Gilead has no protection under the PREP Act. This court decision is a development that might enhance the probability of ensuing class-action lawsuits against pharmaceutical firms.
Now in his 80s, Nowacki enjoyed an active lifestyle with his spouse before receiving Remdesivir at St. Joseph Mercy Chelsea Hospital in eastern Michigan. Unfortunately, he is now a wheelchair user.
At a media briefing last week, Nowacki’s lawyer, Ven Johnson from Johnson Law, revealed that the hospital took several months to verify that Nowacki was administered two doses of Remdesivir containing minute glass fragments. Gilead Sciences, the drug’s maker, voluntarily recalled approximately 55,000 vials of Veklury (the drug’s intravenous form) in December 2021 after acknowledging that they contained glass particles.
The hospital and Gilead attempted to invoke protection under the PREP Act in court but were overruled by the judge.
“You had the medication that was approved, never the glass particulates. So, you do not have drug immunity,” stated Johnson last week, further emphasizing that the lawsuit aims to uncover why St. Joseph’s patients were not alerted about the glass in Gilead’s medication.
The glass particulates in the Remdesivir were not revealed until five months later, and no clients or patients received any notification. They knew their mistake, so they removed it from the market.
Last Sunday, demonstrations were held outside three Michigan hospitals by advocates of medical freedom, highlighting the deadly impact of Remdesivir on their family members. Laurie Madigan, co-chair of the Michigan chapter of the FormerFedsGroup Freedom Foundation, expressed her delight at seeing the case progress.
“My husband died on January 5, 2022 after he was administered Remdesivir. The hospital refuses to reveal the batch numbers of the drugs.
The FormerFedsGroup Freedom Foundation is seeking those whose relatives died after being administered Remdesivir to share their stories for the COVID-19 Humanity Betrayal Memory Project.
